iRhythm Technologies Inc (IRTC)
88.21
+0.08
(+0.09%)
USD |
NASDAQ |
May 31, 16:00
87.98
-0.23
(-0.26%)
After-Hours: 20:00
iRhythm Technologies SG&A Expense (Annual): 385.64M for Dec. 31, 2023
SG&A Expense (Annual) Chart
Historical SG&A Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 385.64M |
| December 31, 2022 | 322.20M |
| December 31, 2021 | 274.84M |
| December 31, 2020 | 197.23M |
| December 31, 2019 | 179.52M |
| Date | Value |
|---|---|
| December 31, 2018 | 133.31M |
| December 31, 2017 | 85.25M |
| December 31, 2016 | 51.62M |
| December 31, 2015 | 36.72M |
| December 31, 2014 | 20.22M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (Annual) Range, Past 5 Years
179.52M
Minimum
2019
385.64M
Maximum
2023
271.89M
Average
274.84M
Median
2021
SG&A Expense (Annual) Benchmarks
| Abbott Laboratories | 10.95B |
| Alphatec Holdings Inc | 374.08M |
| AtriCure Inc | 253.14M |
| Intuitive Surgical Inc | 1.964B |
| RxSight Inc | 74.80M |